Higher hospital surgical volume leads to significantly better outcomes for esophagectomy and gastrectomy patients. 30-day mortality drops to 51% lower (odds ratio 0.51) at high-volume hospitals performing 4-239 resections/year. 90-day mortality reduced by 35% (odds ratio 0.65) and fewer complications observed (odds ratio 0.83). Surgical teams should consider hospital volume when planning procedures. Optimal volume […]
Category: General Surgery
Omitting antibiotics in mild cholecystitis reduces unnecessary use.
Perioperative antibiotics did not significantly lower infectious complications: 9% with antibiotics vs. 12% without. Surgical site infections were also similar: 5% vs. 8%. Surgeons can consider forgoing antibiotics in healthy patients with mild-moderate acute cholecystitis. No differences in length of hospital stay or mortality were observed. Further research is needed for high-risk patient populations. Review […]
Risk Factors for Reoperation After Ileostomy in Colorectal Cancer
Diverting ileostomy significantly reduces the risk of anastomotic leakage during colorectal cancer surgery, but specific risk factors can complicate outcomes. Anastomotic leakage occurred in 17.5% of patients, with lower rectal tumors as the sole significant risk factor (p=0.0095). Reoperation due to leakage was necessary for 19% of these cases, particularly in patients with T4 tumors […]
Predicting Malignancy in Pancreatic Mucinous Cystic Neoplasms
Surgeons can now identify high-grade dysplasia in pancreatic mucinous cystic neoplasms using an effective risk prediction model. In a study of 198 patients, 16% had high-grade dysplasia, with 7% showing invasive carcinoma. Key risk factors include older age (median 52.5 years), symptomatic presentation (72%), cyst size (average 85 mm), and mural nodules (56%). Utilize the […]
Minimally Invasive Surgery Improves Outcomes in Esophageal Cancer
Conversion minimally invasive esophagectomy is a viable option for cT4b esophageal cancer patients previously deemed unresectable, offering significant benefits. Patients undergoing conversion minimally invasive esophagectomy (c-mie) experienced less intraoperative blood loss (79 ml vs. 470 ml, p < 0.001) and a lower risk of anastomotic leakage (4.8% vs. 24%, p = 0.04). ICU stays were […]
Comparative Outcomes in Rectal Cancer Procedures Revealed
Laparoscopy, robotic-assisted, and transanal techniques showed mixed success in high-risk rectal cancer patients, all falling short of expected outcomes. Primary outcome rates: 82.4% (laparoscopy), 64.3% (laparotomy), 74.7% (robotic), and 80.3% (transanal). 96% R0 resection rate across all techniques; no significant difference found. Conversion rates for minimally invasive methods remained consistent at 4.5%. Surgeons should consider […]
Robotic Resection Outperforms Laparoscopic for Minor Liver Surgery
Robotic minor liver resection shows significant benefits over laparoscopic approaches for anterolateral segment surgeries. Median blood loss: 75 ml for robotic versus 100 ml for laparoscopic (p < 0.001). Major morbidity rates: 2.5% for robotic compared to 4.6% for laparoscopic (p = 0.004). Consider integrating robotic techniques to improve patient outcomes, especially for those with […]
New Tool Improves Fistula Risk Prediction in Pancreatoduodenectomy
A newly optimized classification model better predicts postoperative pancreatic fistula risk in patients undergoing pancreatoduodenectomy for periampullary tumors. Overall, the rate of clinically relevant pancreatic fistula was 22.2%, rising to 25.8% specifically for periampullary tumors. The original model showed moderate predictive performance (AUC = 0.632), but the adjusted version improved this to 0.672. Understanding these […]
Critical Margin Assessment in Pancreatic Cancer Surgery
Surgeons must prioritize evaluating specific resection margins in pancreatic cancer for better patient outcomes. Three key margins—superior-mesenteric vein (HR 1.48), medial (HR 1.92), and posterior (HR 1.65)—are significantly linked to disease-free survival. R1 status worsens survival in gemcitabine-treated patients (HR 1.97) but not with mFOLFOXIRI. Aim for thorough margin assessment focusing on these three areas […]
Watch-and-Wait for Rectal Cancer: Key Thresholds Identified
Watch-and-wait may be an option for rectal cancer patients, but specific conditions must be met to avoid worse outcomes. Salvage rates below 75% threaten disease-free survival; rates must stay above this for safety. Ten-year overall survival rates are similar: 83.0% for watch-and-wait vs. 81.5% for surgery. Monitoring regrowth rates is essential; if it exceeds 10% […]